Literature DB >> 8389472

Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.

R C Aloia1, H Tian, F C Jensen.   

Abstract

Previous studies have indicated that human immunodeficiency virus (HIV) is enclosed with a lipid envelope similar in composition to cell plasma membranes and to other viruses. Further, the fluidity, as measured by spin resonance spectroscopy, is low and the viral envelope is among the most highly ordered membranes analyzed. However, the relationship between viral envelope lipids and those of the host cell is not known. Here we demonstrate that the phospholipids within the envelopes of HIV-1RF and HIV-2-L are similar to each other but significantly different from their respective host cell surface membranes. Further, we demonstrate that the cholesterol-to-phospholipid molar ratio of the viral envelope is approximately 2.5 times that of the host cell surface membranes. Consistent with the elevated cholesterol-to-phospholipid molar ratio, the viral envelopes of HIV-1RF and HIV-2-L were shown to be 7.5% and 10.5% more ordered than the plasma membranes of their respective host cells. These data demonstrate that HIV-1 and HIV-2-L select specific lipid domains within the surface membrane of their host cells through which to emerge during viral maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389472      PMCID: PMC46679          DOI: 10.1073/pnas.90.11.5181

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  The membrane structure of lipid-containing viruses.

Authors:  J Lenard; R W Compans
Journal:  Biochim Biophys Acta       Date:  1974-04-08

2.  Lipid composition of Sindbis virus.

Authors:  A E David
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

3.  The lipid class composition of Semliki forest virus and plasma membranes of the host cells.

Authors:  O Renkonen; L Kääräinen; K Simons; C G Gahmberg
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

4.  Plasma membrane lipids and parainfluenza virus assembly.

Authors:  H D Klenk; P W Choppin
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

5.  Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses.

Authors:  J P Quigley; D B Rifkin; E Reich
Journal:  Virology       Date:  1971-10       Impact factor: 3.616

6.  Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells.

Authors:  H D Klenk; P W Choppin
Journal:  Virology       Date:  1969-06       Impact factor: 3.616

7.  Isolation and characterization of lymphocyte plasma membranes.

Authors:  E Ferber; K Resch; D F Wallach; W Imm
Journal:  Biochim Biophys Acta       Date:  1972-05-09

8.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

9.  Lipid composition of purified vesicular stomatitis viruses.

Authors:  J J McSharry; R R Wagner
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

10.  The ratio of plasma membrane cholesterol to phospholipid and the inhibition of Sindbis virus maturation by low NaCl medium.

Authors:  R F Garry; D A Bostick; R Schram; M R Waite
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

View more
  200 in total

1.  Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.

Authors:  V M Vogt; M N Simon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Minimal exclusion of plasma membrane proteins during retroviral envelope formation.

Authors:  M Hammarstedt; K Wallengren; K W Pedersen; N Roos; H Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

Authors:  I Rousso; M B Mixon; B K Chen; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Modulation of HIV-like particle assembly in vitro by inositol phosphates.

Authors:  S Campbell; R J Fisher; E M Towler; S Fox; H J Issaq; T Wolfe; L R Phillips; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

6.  Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus.

Authors:  Xiongbin Lu; Ying Xiong; Jonathan Silver
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.

Authors:  Rabih Halwani; Ahmad Khorchid; Shan Cen; Lawrence Kleiman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization.

Authors:  A James Mason; Arnaud Marquette; Burkhard Bechinger
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

9.  Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.

Authors:  Mireille Guyader; Etsuko Kiyokawa; Laurence Abrami; Priscilla Turelli; Didier Trono
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.

Authors:  S Mediouni; J A Jablonski; S Tsuda; A Barsamian; C Kessing; A Richard; A Biswas; F Toledo; V M Andrade; Y Even; M Stevenson; T Tellinghuisen; H Choe; M Cameron; T D Bannister; S T Valente
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.